Screener
Haemonetics HAE Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's net income?
- Haemonetics (HAE) reported net income of $33.01M in Q2 2026.
- How has Haemonetics's net income changed year-over-year?
- Haemonetics's net income decreased by 3.0% year-over-year, from $34.03M to $33.01M.
- What is the long-term trend for Haemonetics's net income?
- Over 3 years (2022 to 2025), Haemonetics's net income has grown at a 56.9% compound annual growth rate (CAGR), from $43.38M to $167.68M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Haemonetics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude